The effects of race/ethnicity and sex on the risk of venous thromboembolism

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 5, 2007, Pages 377-383

  Keenan, Craig R ^a   White, Richard H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Emergency Medicine   (United States)

Author keywords

Ethnicity; Gender; Race; Venous thromboembolism

Indexed keywords

AFRICAN AMERICAN; ASIAN; CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CARDIOVASCULAR RISK; CAUCASIAN; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; HISPANIC; HUMAN; PACIFIC ISLANDER; PREVALENCE; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; VENOUS THROMBOEMBOLISM;

AFRICAN AMERICANS; ASIAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; RISK FACTORS; SEX CHARACTERISTICS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 34748913691     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3281eb8ef0     Document Type: Review

References (37)

1. Dilley A, Austin H, Hooper WC, et al. Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med 1998; 132:452-455.
2. Hira B, Pegoraro RJ, Rom L, Moodley J. Absence of Factor V Leiden, thrombomodulin and prothrombin gene variants in Black South African women with preeclampsia and eclampsia. BJOG 2003; 110:327-328.
3. Hooper WC, Dilley A, Ribeiro MJ, et al. A racial difference in the prevalence of the Arg506→Gln mutation. Thromb Res 1996; 81:577-581.
4. Itakura H. Racial disparities in risk factors for thrombosis. Curr Opin Hematol 2005; 12:364-369.
5. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277:1305-1307.
6. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (23 Suppl 1):I4-I8.
7. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992; 152:1660-1664.
8. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151:933-938.
9. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86:452-463.
10. Kniffin WD Jr, Baron JA, Barrett J, et al. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154:861-866.
11. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158:585-593.
12. Stein PD, Kayali F, Olson RE, Milford CE. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 2004; 116:435-442.
13. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998; 128:737-740.
14. Agnelli G, Becattini C, Prandoni P. Recurrent venous thromboembolism in men and women. N Engl J Med 2004; 351:2015-2018; author reply -8.
15. Baglin T, Luddington R, Brown K, Baglin C. High risk of recurrent venous thromboembolism in men. J Thromb Haemost 2004; 2:2152-2155.
16. Kyrle PA, Minar E, Bialonczyk C, et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350:2558-2563.
17. Nieto JA, Monreal M. Recurrent venous thromboembolism in men and women. N Engl J Med 2004; 351:2015-2018; author reply 2018.
18. Hansson PO, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160:769-774.
19. White RH, Zhou H, Gage BF. Effect of age on the incidence of venous thromboembolism after major surgery. J Thromb Haemost 2004; 2:1327-1333.
20. White RH, Zhou H, Murin S, Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93:298-305.
21. Siddique RM, Siddique MI, Connors AF Jr, Rimm AA. Thirty-day case-fatality rates for pulmonary embolism in the elderly. Arch Intern Med 1996; 156: 2343-2347.
22. Stein PD, Kayali F, Olson RE. Estimated case fatality rate of pulmonary embolism, 1979 to 1998. Am J Cardiol 2004; 93:1197-1199.
23. Schneider D, Lilienfeld DE, Im W. The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. J Natl Med Assoc 2006; 98:1967-1972. The authors report data from New Jersey discharge dataset showing continued high incidence of VTE in black men and women versus whites, though in-hospital fatality did not differ.
24. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000; 85:1334-1337.
25. Chau KY, Yuen ST, Wong MP. Clinicopathological pattern of pulmonary thromboembolism in Chinese autopsy patients: comparison with Caucasian series. Pathology 1997; 29:263-266.
26. Leizorovicz A, Turpie AG, Cohen AT, et al. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study. J Thromb Haemost 2005; 3: 28-34.
27. Sakon M, Maehara Y, Yoshikawa H, Akaza H. Incidence of venous thromboembolism following major abdominal surgery: a multicenter, prospective epidemiological study in Japan. J Thromb Haemost 2006; 4:581-586. Prospective study did venograms on all 173 patients and found incidence of VTE of 24% after major abdominal surgery in Japanese patients, which is comparable to old studies in non-Asian paitents. Most, however, were calf DVT and only one patient symptomatic (with pulmonary embolism).
28. White RH, Dager WE, Zhou H, Murin S. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006; 96:267-273. This study of large, racially diverse California population studying VTE recurrence after idiopathic VTE found that VTE recurrence was lowest in Caucasian women, and increased risk in other groups varied by sex, ethnicity, and type of index VTE event (DVT or pulmonary embolism).
29. Garcia-Fuster MJ, Forner MJ, Fernandez C, et al. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years. Pathophysiol Haemost Thromb 2005; 34:6-12.
30. Eriksson H, Lundstrom T, Wahlander K, et al. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran. Thromb Haemost 2005; 94:522-527.
31. Cushman M, Glynn RJ, Goldhaber SZ, et al. Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost 2006; 4:2199-2203. This is an analysis by sex of the participant in the PREVENT study of low dose warfarin versus placebo for prevention of VTE recurrence. Women on oral contraceptive, hormone replacement therapy or who were pregnant had markedly lower risk of recurrence than men, but women without these hormonal risks had only a nonsignificant reduction. Implies that women without 'hormonal' risk factors may not have a lower risk of recurrence than men.
32. van Hylckama Vlieg A, Baglin CA, Baglin TP. Is there a true difference in recurrence rate of deep venous thrombosis between men and women? J Thromb Haemost 2005; 3:2113-2114.
33. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160:809-815.
34. Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166:458-464. This large study of over 235 000 Californians with cancer analyzed the incidence of VTE at the time of diagnosis and within 2 years after diagnosis. It enumerates the magnitude and time course of VTE after diagnosis of common cancers, and identifies metastatic cancer as the strongest predictor of VTE. It also describes marked reduction in risk for Asian/Pacific Islanders, and describes risk in other ethnic and sex groups.
35. Stein PD, Beemath A, Meyers FA, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 2006; 119:60-68. This study of the huge National Hospital Discharge Survey dataset reported the incidence of VTE in patients with 19 common cancers. Overall incidence was 1.0%, with the highest being 4.3% in patients with pancreatic carcinoma. No overall differences in race or sex were found.
36. Wells PS. Advances in the diagnosis of venous thromboembolism. J Thromb Thrombolysis 2006; 21:31-40.
37. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119 (1 Suppl):176S-193S.